Skip to main content
SpringerLink
Log in

Interdisziplinäre Handlungsempfehlung bei Dupilumab-assoziierten entzündlichen Augenerkrankungen

Interdisciplinary recommendations for action in dupilumab-related inflammatory eye diseases

  • In der Diskussion
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Agrahari V, Mandal A, Agrahari V et al (2016) A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res 6:735–754

    Article  CAS  Google Scholar 

  2. Awwad S, Angkawinitwong U (2018) Overview of antibody drug delivery. Pharmaceutics 10. https://doi.org/10.3390/pharmaceutics10030083

    Article  PubMed  PubMed Central  Google Scholar 

  3. Barnes AC, Blandford AD, Perry JD (2017) Cicatricial ectropion in a patient treated with dupilumab. Am J Ophthalmol Case Rep 7:120–122

    Article  Google Scholar 

  4. Chen JJ, Applebaum DS, Sun GS et al (2014) Atopic keratoconjunctivitis: a review. J Am Acad Dermatol 70:569–575

    Article  Google Scholar 

  5. De Bruin-Weller M, Graham NMH, Pirozzi G et al (2018) Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors. Br J Dermatol. https://doi.org/10.1111/bjd.16348

    Article  PubMed  PubMed Central  Google Scholar 

  6. De Majumdar S, Subinya M, Korward J et al (2017) A low concentration of Tacrolimus/Semifluorinated Alkane (SFA) eyedrop suppresses Intraocular inflammation in experimental models of uveitis. Curr Mol Med 17:211–220

    Article  CAS  Google Scholar 

  7. Elias PM (2018) Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis. Exp Dermatol 27:847–851

    Article  CAS  Google Scholar 

  8. Fujitsu Y, Fukuda K, Kumagai N et al (2003) IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Exp Eye Res 76:107–114

    Article  CAS  Google Scholar 

  9. Gavrilova T (2018) Immune dysregulation in the pathogenesis of atopic dermatitis. Dermatitis 29:57–62

    CAS  PubMed  Google Scholar 

  10. Gooderham M, Mcdonald J, Papp K (2018) Diagnosis and management of conjunctivitis for the dermatologist. J Cutan Med Surg 22:200–206

    Article  Google Scholar 

  11. Gooderham MJ, Hong HC, Eshtiaghi P et al (2018) Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol 78:S28–S36

    Article  CAS  Google Scholar 

  12. Kim H, Robinson SB, Csaky KG (2009) FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye. Mol Vis 15:2803–2812

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Maier P, Lapp T, Reinhard T (2017) Ocular involvement in atopic dermatitis : clinical aspects and therapy. Ophthalmologe 114:514–524

    Article  CAS  Google Scholar 

  14. Mennini M, Dahdah L, Fiocchi A (2017) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 376:1090

    Article  Google Scholar 

  15. Nowicka D, Grywalska E (2018) The role of immune defects and colonization of staphylococcus aureus in the pathogenesis of atopic dermatitis. Anal Cell Pathol (Amst) 2018:1956403

    PubMed  PubMed Central  Google Scholar 

  16. Pflugfelder SC, De Paiva CS (2017) The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 124:S4–S13

    Article  Google Scholar 

  17. Pharmazeutisches Laboratorium des DAC/NRF (2019) Standardisierte Rezepturen. Formelsammlung für Ärzte. Govi, Eschborn

    Google Scholar 

  18. Pleyer U, Ursell PG, Rama P (2013) Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same? Ophthalmol Ther 2:55–72

    Article  Google Scholar 

  19. Scheerer C, Eyerich K (2018) Pathogenesis of atopic dermatitis. Hautarzt 69:191–196

    Article  CAS  Google Scholar 

  20. Seegraber M, Srour J, Walter A et al (2018) Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol 11:467–474

    Article  Google Scholar 

  21. Simpson EL, Akinlade B, Ardeleanu M (2017) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 376:1090–1091

    Article  Google Scholar 

  22. Thyssen JP (2018) Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels? Br J Dermatol 178(5):1220. https://doi.org/10.1111/bjd.16330

    Article  CAS  PubMed  Google Scholar 

  23. Treister AD, Kraff-Cooper C, Lio PA (2018) Risk factors for dupilumab-associated conjunctivitis in patients with atopic dermatitis. Jama Dermatol 154:1208. https://doi.org/10.1001/jamadermatol.2018.2690

    Article  PubMed  Google Scholar 

  24. Wang FP, Tang XJ, Wei CQ et al (2018) Dupilumab treatment in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. J Dermatol Sci 90:190–198

    Article  CAS  Google Scholar 

  25. Werfel T, Heratizadeh A, Aberer W et al (2016) S2k guideline on diagnosis and treatment of atopic dermatitis—short version. Allergo J Int 25:82–95

    Article  Google Scholar 

  26. Wohlrab J (2015) Pharmacokinetic characteristics of therapeutic antibodies. J Dtsch Dermatol Ges 13:530–534

    PubMed  Google Scholar 

  27. Wollenberg A, Ariens L, Thurau S et al (2018) Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment. J Allergy Clin Immunol Pract 6:1778. https://doi.org/10.1016/j.jaip.2018.01.034

    Article  PubMed  Google Scholar 

  28. Wollenberg A, Barbarot S, Bieber T et al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 32:657–682

    Article  CAS  Google Scholar 

  29. Wollenberg A, Barbarot S, Bieber T et al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 32:850–878

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle/Saale, Deutschland

    Johannes Wohlrab

  2. An-Institut für angewandte Dermatopharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle, Deutschland

    Johannes Wohlrab

  3. Klinik für Dermatologie und Allergologie, Ludwig-Maximilian-Universität München, München, Deutschland

    Andreas Wollenberg

  4. Avoxa – Mediengruppe Deutscher Apotheker GmbH, Eschborn, Deutschland

    Holger Reimann

  5. Universitätsmedizin Berlin, Klinik für Augenheilkunde, Charité, Berlin, Deutschland

    Uwe Pleyer

  6. Klinik für Dermatologie und Allergologie, Medizinische Hochschule Hannover, Hannover, Deutschland

    Thomas Werfel

Authors
  1. Johannes Wohlrab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Wollenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Holger Reimann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Uwe Pleyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Werfel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes Wohlrab.

Ethics declarations

Interessenkonflikt

J. Wohlrab, A. Wollenberg, H. Reimann, U. Pleyer und T. Werfel geben an, dass sie Honorarbezüge für Vorträge und/oder Beratung von Sanofi-Aventis erhalten haben. Die Inhalte der vorliegenden Handlungsempfehlungen wurden von den Autoren unabhängig und ohne Vorgaben Dritter erstellt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wohlrab, J., Wollenberg, A., Reimann, H. et al. Interdisziplinäre Handlungsempfehlung bei Dupilumab-assoziierten entzündlichen Augenerkrankungen. Hautarzt 70, 64–67 (2019). https://doi.org/10.1007/s00105-018-4316-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-018-4316-1

Search

Navigation